Interactions between tumor and immune cells via programmed cell death 1/programmed cell death receptor ligand 1 (PD-1/PD-L1) pathway and the cytotoxic T-lymphocyte antigen 4 (CTLA4) system are potential therapeutic targets in many solid cancers. The gene discussed is CD274; the disease is neoplasm.